Dr.Reddys Laboratories | DRRD - Sales Revenues

Stock Price
1,217.30
Daily Change
7.70 0.64%
Monthly
-5.72%
Yearly
5.72%
Q2 Forecast
1,255.04

Dr.Reddys Laboratories reported INR87.27B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Aspen Pharmacare ZAR 17.08B 4.32B Dec/2025
Bharat Petroleum INR 1.09T 0 Dec/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025